Future research is focusing on understanding the metabolic heterogeneity within tumors and identifying biomarkers that can predict response to metabolic therapies. Additionally, combining metabolic inhibitors with other therapies, such as immunotherapy, is being explored to enhance treatment efficacy. Advances in metabolomics and imaging technologies will also aid in better understanding and targeting cancer metabolism.
